Literature DB >> 22374155

Reducing oral flora contamination of intravitreal injections with face mask or silence.

Rishi R Doshi1, Theodore Leng, Anne E Fung.   

Abstract

PURPOSE: To provide experimental evidence to support or refute the proposition that the use of surgical face masks and/or avoidance of talking can decrease the dispersion of respiratory flora during an intravitreal injection.
METHODS: Ten surgeons recited a 30-second standardized script with blood agar plates positioned 30 cm below their mouths. The plates were divided into 4 groups, with 10 plates per group. In Group 1, participants did not wear a face mask. In Group 2, participants wore a standard surgical mask. In Group 3, no mask was worn, but plates were pretreated with 5% povidone-iodine. In Group 4, no mask was worn, and participants remained silent for 30 seconds. The plates were then incubated at 37°C for 24 hours, and the number of colony-forming units (CFUs) was determined.
RESULTS: Mean bacterial growth were as follows: Group 1, 8.6 CFUs per subject; Group 2, 1.1 CFUs per subject; Group 3, 0.1 CFUs per subject; and Group 4, 2.4 CFUs per subject. Differences between the groups were statistically significant (P < 0.05), with the exception of Group 2 versus Group 4 (P = 0.115).
CONCLUSION: The use of a face mask and avoidance of talking each significantly decreased the dispersion of bacteria. Even without these interventions, plates pretreated with povidone-iodine demonstrated the least bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374155     DOI: 10.1097/IAE.0B013E31822C2958

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  29 in total

1.  Comment on bilateral same-session intravitreal injections.

Authors:  Levent Karabas; Fehim Esen; Ozlem Sahin
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 2.  Prevention and treatment of injection-related endophthalmitis.

Authors:  Charles Q Yu; Christopher N Ta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-08       Impact factor: 3.117

Review 3.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

4.  Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.

Authors:  Hiroyuki Shimada; Takayuki Hattori; Ryusaburo Mori; Hiroyuki Nakashizuka; Kyoko Fujita; Mitsuko Yuzawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

5.  Culture-Proven Endophthalmitis After Intravitreal Injection: A 10-Year Analysis.

Authors:  Joseph M Simonett; Austin Igelman; Stanford C Taylor; J Peter Campbell; Thomas S Hwang; Phoebe Lin; Andreas K Lauer; Christina J Flaxel
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-01-01       Impact factor: 1.300

6.  Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

7.  Intravitreal air bubbles following intravitreal injections: a comprehensive analysis.

Authors:  Mark Krauthammer; Etty Trabelsi; Elad Moisseiev
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-14       Impact factor: 3.117

8.  Endophthalmitis: a bibliographic review.

Authors:  Christian I Wade; Todd D Whitescarver; Cody R Ashcroft; Samuel D Hobbs; Boonkit Purt; Ashvini K Reddy; Marcus H Colyer; Grant A Justin
Journal:  Int Ophthalmol       Date:  2021-07-27       Impact factor: 2.031

Review 9.  Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.

Authors:  K Ghasemi Falavarjani; Q D Nguyen
Journal:  Eye (Lond)       Date:  2013-05-31       Impact factor: 3.775

Review 10.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.